A functional Notch–survivin gene signature in basal breast cancer

IntroductionBasal-type, or triple-negative, breast cancer (lacking estrogen receptor, progesterone receptor, and human epidermal growth factor receptor-2 expression) is a high-risk disease for which no molecular therapies are currently available. We studied genetic signatures of basal breast cancer potentially suitable for therapeutic intervention.MethodsWe analyzed protein expression of the Notch-1 intracellular domain and survivin by immunohistochemistry in a series of basal breast cancer patients. A hierarchical clustering and overall survival analysis was carried out on a microarray mRNA database of 232 breast cancer patients. Fifteen published mRNA datasets containing estrogen receptor-negative or estrogen receptor-positive samples were subjected to meta-analysis for co-segregated gene expression. Experiments of plasmid transfection and gene silencing were carried out in estrogen receptor-negative MDA-MB-231 breast cancer cells.ResultsThe developmental signaling regulator Notch-1 was highly expressed in breast cancer, compared with normal tissue, and was segregated with basal disease. Higher Notch-1 levels correlated with progressively abbreviated overall survival, and with increased expression of survivin, a tumor-associated cell death and mitotic regulator implicated in stem cell viability. Analysis of Pearson's correlation coefficient indicated that Notch-1 and survivin co-segregated in basal breast cancer. Notch-1 stimulation in MDA-MB-231 cells increased survivin expression, whereas silencing Notch reduced survivin levels.ConclusionsA Notch-1–survivin functional gene signature is a hallmark of basal breast cancer, and may contribute to disease pathogenesis. Antagonists of Notch and survivin currently in the clinic may be tested as novel molecular therapy for these recurrence-prone patients.

• Publication year

  2008

• Venue

  Breast Cancer Research

• Publication date

  2008-11-24

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1186/bcr2200PMID 19025652PMCID 2656893
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cross-talk between notch and the estrogen receptor in breast cancer suggests novel therapeutic approaches.

  2008cited by this paper
• Transcriptome analysis of the normal human mammary cell commitment and differentiation process.

  2008cited by this paper
• Survivin, cancer networks and pathway-directed drug discovery

  2008cited by this paper
• Molecular dependence of estrogen receptor-negative breast cancer on a notch-survivin signaling axis.

  2008influential reference
• Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity

  2007cited by this paper
• Requirements for survivin in terminal differentiation of erythroid cells and maintenance of hematopoietic stem and progenitor cells

  2007cited by this paper
• IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland.

  2007cited by this paper
• Epidermal growth factor receptor mutations in lung cancer

  2007cited by this paper
• The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer Subtypes

  2007cited by this paper
• Triple-negative breast cancer: therapeutic options.

  2007cited by this paper
• Notch Signaling, γ-Secretase Inhibitors, and Cancer Therapy: Figure 1.

  2007cited by this paper
• Stem cell-associated genes are extremely poor prognostic factors for soft-tissue sarcoma patients

  2007cited by this paper
• Survivin Identifies Keratinocyte Stem Cells and Is Downregulated by Anti‐β1 Integrin During Anoikis

  2007cited by this paper
• Taking gene-expression profiling to the clinic: when will molecular signatures become relevant to patient care?

  2007cited by this paper
• Strong Time Dependence of the 76-Gene Prognostic Signature for Node-Negative Breast Cancer Patients in the TRANSBIG Multicenter Independent Validation Series

  2007cited by this paper
• The prognostic role of a gene signature from tumorigenic breast-cancer cells.

  2007cited by this paper
• Novel cell culture technique for primary ductal carcinoma in situ: role of Notch and epidermal growth factor receptor signaling pathways.

  2007cited by this paper
• DNA methylation profiling of myelodysplastic syndrome hematopoietic progenitor cells during in vitro lineage-specific differentiation.

  2007cited by this paper
• Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors

  2007influential reference
• Notch signaling, gamma-secretase inhibitors, and cancer therapy.

  2007cited by this paper
• Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis

  2007cited by this paper
• Genomic and transcriptional aberrations linked to breast cancer pathophysiologies.

  2006cited by this paper
• Mechanisms of Disease: oncogene addiction—a rationale for molecular targeting in cancer therapy

  2006cited by this paper
• Notch signalling: a simple pathway becomes complex

  2006cited by this paper
• Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer.

  2006cited by this paper
• Demystifying basal-like breast carcinomas

  2006cited by this paper
• Activated checkpoint kinase 2 provides a survival signal for tumor cells.

  2006cited by this paper
• Mitosis-independent survivin gene expression in vivo and regulation by p53.

  2006cited by this paper
• Wnt/beta-catenin signaling in development and disease.

  2006cited by this paper
• A Modular Analysis of Breast Cancer Reveals a Novel Low-Grade Molecular Signature in Estrogen Receptor–Positive Tumors

  2006cited by this paper
• Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer.

  2006cited by this paper
• X chromosomal abnormalities in basal-like human breast cancer.

  2006cited by this paper
• Prognosis and Gene Expression Profiling of 20q13-Amplified Breast Cancers

  2006cited by this paper
• The canonical Notch/RBP-J signaling pathway controls the balance of cell lineages in mammary epithelium during pregnancy.

  2006cited by this paper
• Aberrant Activation of Notch Signaling in Human Breast Cancer

  2006cited by this paper
• Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis.

  2006cited by this paper
• Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer.

  2005cited by this paper
• Phase II and tumor pharmacodynamic study of gefitinib in patients with advanced breast cancer.

  2005cited by this paper
• An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival.

  2005cited by this paper
• Genes that mediate breast cancer metastasis to lung

  2005cited by this paper
• High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival.

  2005cited by this paper
• Purification of neuronal precursors from the adult mouse brain: comprehensive gene expression analysis provides new insights into the control of cell migration, differentiation, and homeostasis.

  2004cited by this paper
• Chronic treatment with the gamma-secretase inhibitor LY-411,575 inhibits beta-amyloid peptide production and alters lymphopoiesis and intestinal cell differentiation.

  2004cited by this paper
• Different gene expression patterns in invasive lobular and ductal carcinomas of the breast.

  2004influential reference
• Oncogene addiction: sometimes a temporary slavery.

  2004cited by this paper
• ONCOMINE: a cancer microarray database and integrated data-mining platform.

  2004cited by this paper
• Breast cancer, stem/progenitor cells and the estrogen receptor.

  2004cited by this paper
• Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma

  2004cited by this paper
• Chronic Treatment with the γ-Secretase Inhibitor LY-411,575 Inhibits β-Amyloid Peptide Production and Alters Lymphopoiesis and Intestinal Cell Differentiation*

  2004cited by this paper
• Java Treeview - extensible visualization of microarray data

  2004cited by this paper
• A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer.

  2004cited by this paper
• Mitochondrial survivin inhibits apoptosis and promotes tumorigenesis.

  2004cited by this paper
• Survivin and molecular pathogenesis of colorectal cancer.

  2003cited by this paper
• Breast cancer classification and prognosis based on gene expression profiles from a population-based study

  2003cited by this paper
• A p34(cdc2) survival checkpoint in cancer.

  2002cited by this paper
• Signalling: γ-Secretase-mediated proteolysis in cell-surface-receptor signalling

  2002cited by this paper
• A gene-expression signature as a predictor of survival in breast cancer.

  2002cited by this paper
• Gene expression profiling predicts clinical outcome of breast cancer

  2002cited by this paper
• Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

  2001cited by this paper
• Induction of Cyclin D1 Transcription and CDK2 Activity by Notchic: Implication for Cell Cycle Disruption in Transformation by Notchic

  2001cited by this paper
• Molecular portraits of human breast tumours

  2000cited by this paper
• Cluster analysis and display of genome-wide expression patterns.

  1998cited by this paper
• Meta-analysis in clinical trials.

  1986cited by this paper
• Applied Regression Analysis and Other Multivariate Methods

  1978cited by this paper

• The involvement of exosomes in the tumorigenicity of breast cancer cell lines through the crosstalk between STAT3, Notch, and Wnt signaling pathways

  2025cites this paper
• Beauvericin Reverses Epithelial-to-Mesenchymal Transition in Triple-Negative Breast Cancer Cells through Regulation of Notch Signaling and Autophagy.

  2024cites this paper
• Brain metastasis in breast cancer: focus on genes and signaling pathways involved, blood–brain barrier and treatment strategies

  2023cites this paper
• Loss of the receptors ER, PR and HER2 promotes USP15-dependent stabilization of PARP1 in triple-negative breast cancer

  2023cites this paper
• Notch1 signaling modulates hypoxia-induced multidrug resistance in human laryngeal cancer cells

  2022cites this paper
• Expression of NOTCH1, NOTCH4, HLA-DMA and HLA-DRA is synergistically associated with T cell exclusion, immune checkpoint blockade efficacy and recurrence risk in ER-negative breast cancer

  2022cites this paper
• Transcriptomic profiling of Indian breast cancer patients revealed subtype-specific mRNA and lncRNA signatures

  2022cites this paper
• Wnt Signaling in the Breast: From Development to Disease

  2022cites this paper
• A comprehensive study of mRNA and long noncoding RNAs in Indian Breast cancer patients using transcriptomics approach

  2022cites this paper
• Mathematical Modeling of Locoregional Recurrence Caused by Premalignant Lesions Formed Before Initial Treatment

  2021cites this paper
• Survivin promotes rheumatoid arthritis fibroblast‐like synoviocyte cell proliferation, and the expression of angiogenesis‐related proteins by activating the NOTCH pathway

  2021cites this paper
• Prognostic Significance of BIRC5/Survivin in Breast Cancer: Results from Three Independent Cohorts

  2021cites this paper
• Notch Signaling and the Breast Cancer Microenvironment.

  2021cites this paper
• Notch Signaling in Embryology and Cancer: Notch Signaling in Cancer

  2021cites this paper
• Notch1 Signaling Modulates Hypoxia-induced Multidrug Resistance of Human Laryngeal Cancer Cells

  2021cites this paper
• Notch Signalling in Breast Development and Cancer

  2021cites this paper
• The Performance of Gene Expression Signature-Guided Drug–Disease Association in Different Categories of Drugs and Diseases

  2020cites this paper
• Notch-Inflammation Networks in Regulation of Breast Cancer Progression

  2020cites this paper
• Notch Signaling Activation as a Hallmark for Triple-Negative Breast Cancer Subtype

  2019cites this paper
• MFAP5 promotes basal-like breast cancer progression by activating the EMT program

  2019cites this paper
• Notch-Mediated Tumor-Stroma-Inflammation Networks Promote Invasive Properties and CXCL8 Expression in Triple-Negative Breast Cancer

  2019cites this paper
• Chapter 2 Cancer Stem Cells in Breast Cancer

  2018cites this paper
• Positive feedback loop between mitochondrial fission and Notch signaling promotes survivin-mediated survival of TNBC cells

  2018cites this paper
• Notch and Wnt Dysregulation and Its Relevance for Breast Cancer and Tumor Initiation

  2018cites this paper
• The potential pathway of FOXC1 high expression in regulating the proliferation, migration, cell cycle and epithelialmesenchymal transition of basal-like breast cancer and in vivo imaging.

  2018cites this paper
• Organ-specific metastasis of breast cancer: molecular and cellular mechanisms underlying lung metastasis

  2018cites this paper
• Evaluation of survivin immunoexpression in the differentiation of high- and low-grade breast ductal carcinoma in situ

  2018cites this paper
• The Role of Notch in Breast Cancer

  2018cites this paper
• Cancer Stem Cells in Breast Cancer 2 . 1 . 2 Initiation and Disease Progression

  2017cites this paper
• Notch Shapes the Innate Immunophenotype in Breast Cancer.

  2017cites this paper
• Notch inhibitors and their role in the treatment of triple negative breast cancer: promises and failures

  2017cites this paper
• Chemotherapy Sensitivity of Gastric Cancer

  2017cites this paper
• Targeting Notch 1 inhibits invasion and growth of ovarian cancer cell through regulation of miR-124 / flotillin-1 pathway

  2017cites this paper
• Fundamental Pathways in Breast Cancer 4: Signaling to Chromatin in Breast Development

  2017cites this paper
• Prognostic Subcellular Notch2, Notch3 and Jagged1 Localization Patterns in Early Triple-negative Breast Cancer.

  2017cites this paper
• Translational Challenges and Therapeutic Opportunities in BRCA1-Related Breast Cancer

  2017cites this paper
• Non-coding RNAs in Mammary Gland Development and Disease.

  2016cites this paper
• KRT19 directly interacts with β-catenin/RAC1 complex to regulate NUMB-dependent NOTCH signaling pathway and breast cancer properties

  2016cites this paper
• Subclasificación de los tipos moleculares de cáncer de mama de acuerdo a la expresión de marcadores inmunohistoquímicos y evolución

  2016cites this paper
• Chrysin inhibits growth and induces apoptosis of anaplastic thyroid cancer cells via Notch-1 / Slug / PUMA signals

  2016cites this paper
• Curcumin inhibits invasive capabilities through epithelial mesenchymal transition in breast cancer cell lines.

  2016cites this paper
• Protein Kinase C Alpha in Breast Cancer: A Focus on Endocrine Resistant and Triple Negative Breast Cancer

  2016cites this paper
• ROLE OF IRF 6 IN NOTCH REGULATED APOPTOSIS , CELL CYCLE AND DIFFERENTIATION IN BREAST EPITHELIAL CELLS

  2016cites this paper
• Novel Cancer Therapies by Molecular Targeting Distinct Growth Factor Pathways and Drug Resistance-Associated Molecules in Cancer- and Metastasis-Initiating Cells

  2016cites this paper
• Subclassification of the molecular types of breast cancer based on the expression of immunohistochemical markers and evolution.

  2016cites this paper
• Prophylactic Cranial Irradiation Reduces the Incidence of Brain Metastasis in a Mouse Model of Metastatic Breast Cancer

  2015influential citation
• Notch Reporter Activity in Breast Cancer Cell Lines Identifies a Subset of Cells with Stem Cell Activity

  2015cites this paper
• Notch Cooperates with Survivin to Maintain Stemness and to Stimulate Proliferation in Human Keratinocytes during Ageing

  2015influential citation
• MiR-139-5p inhibits the biological function of breast cancer cells by targeting Notch1 and mediates chemosensitivity to docetaxel.

  2015cites this paper
• Notch4 Signaling Confers Susceptibility to TRAIL‐Induced Apoptosis in Breast Cancer Cells

  2015cites this paper
• Cancer stem cells in basic science and in translational oncology: can we translate into clinical application?

  2015cites this paper
• Investigation of Ring Finger Protein 8 in Mammalian Physiology and Pathogenesis

  2015cites this paper
• The Vacuolar ATPase a2-subunit regulates Notch signaling in triple-negative breast cancer cells

  2015cites this paper
• Expansion of stem cells counteracts age-related mammary regression in compound Timp1/Timp3 null mice

  2015cites this paper
• Differential Effect of Phosphorylation-Defective Survivin on Radiation Response in Estrogen Receptor-Positive and -Negative Breast Cancer

  2015cites this paper
• NotchReporterActivity inBreastCancerCell Lines Identi fi es a Subset of Cells with Stem Cell Activity

  2015cites this paper
• Overexpression of Id1 in transgenic mice promotes mammary basal stem cell activity and breast tumorigenesis

  2015cites this paper
• Notch Regulation in Breast Cancer

  2015cites this paper
• NILCO biomarkers in breast cancer from Chinese patients

  2014cites this paper
• New targeted therapies for breast cancer: A focus on tumor microenvironmental signals and chemoresistant breast cancers.

  2014cites this paper
• Visfatin promotes cell and tumor growth by upregulating Notch1 in breast cancer

  2014cites this paper
• Notch-EGFR/HER2 Bidirectional Crosstalk in Breast Cancer

  2014cites this paper
• Targeting Met and Notch in the Lfng-deficient, Met-amplified triple-negative breast cancer

  2014cites this paper
• Signaling pathways in breast cancer: therapeutic targeting of the microenvironment.

  2014cites this paper
• A computational approach to identify predictive gene signatures in Triple Negative Breast Cancer

  2014cites this paper
• Chromatinized Protein Kinase C-θ Directly Regulates Inducible Genes in Epithelial to Mesenchymal Transition and Breast Cancer Stem Cells

  2014cites this paper
• Oncogenic role and therapeutic target of leptin signaling in colorectal cancer

  2014cites this paper
• Prolyl-isomerase Pin1 controls normal and cancer stem cells of the breast

  2013cites this paper
• Knockdown of TRB3 induces apoptosis in human lung adenocarcinoma cells through regulation of Notch 1 expression.

  2013cites this paper
• Notch: evidence for combining therapies to treat breast cancer

  2013cites this paper
• Developmental signaling pathways in cancer stem cells of solid tumors.

  2013cites this paper
• Synergistic Effect of the γ‐Secretase Inhibitor PF‐03084014 and Docetaxel in Breast Cancer Models

  2013cites this paper
• High throughput kinase inhibitor screens reveal TRB3 and MAPK-ERK/TGFβ pathways as fundamental Notch regulators in breast cancer

  2013cites this paper
• Combining Notch inhibition with current therapies for breast cancer treatment

  2013influential citation
• The functional role of Notch signaling in triple-negative breast cancer.

  2013cites this paper
• Trastuzumab-resistant cells rely on a HER2-PI3K-FoxO-survivin axis and are sensitive to PI3K inhibitors.

  2013influential citation
• Cyclin D1-dependent induction of luminal inflammatory breast tumors by activated notch3.

  2013cites this paper
• Chapter VEGF Signaling in Normal and Tumor Angiogenesis

  2013cites this paper
• Regulation of angiogenesis via Notch signaling in breast cancer and cancer stem cells.

  2013cites this paper
• Aurora A kinase regulates mammary epithelial cell fate by determining mitotic spindle orientation in a Notch-dependent manner.

  2013cites this paper
• γ-Secretase Components as Predictors of Breast Cancer Outcome

  2013cites this paper
• The prognostic value of survivin expression in patients with colorectal carcinoma: a meta-analysis.

  2013cites this paper
• Cancer stem cell theory: therapeutic implications for nanomedicine

  2013cites this paper
• Targeting the Akt kinase to modulate survival, invasiveness and drug resistance of cancer cells.

  2013cites this paper
• Correlation of Notch1, pAKT and nuclear NF-κB expression in triple negative breast cancer.

  2013cites this paper
• FOXC1 regulates the functions of human basal-like breast cancer cells by activating NF-κB signaling

  2012cites this paper
• Targeted therapy for triple‐negative breast cancer: Where are we?

  2012cites this paper
• Notch signaling and breast cancer.

  2012cites this paper
• Regulation of Angiogenesis in Human Cancer via Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2)

  2012cites this paper
• Notch-1 and Notch-4 Biomarker Expression in Triple-Negative Breast Cancer

  2012influential citation
• Oncogenic role and therapeutic target of leptin signaling in breast cancer and cancer stem cells.

  2012cites this paper
• Aberrant activation of Notch signalling in breast cancer Several groups have now reported altered expression of Notch pathway components in breast

  2012influential citation
• Lunatic fringe deficiency cooperates with the Met/Caveolin gene amplicon to induce basal-like breast cancer.

  2012cites this paper
• Endogenous knockdown of survivin improves chemotherapeutic response in ALL models

  2012cites this paper
• Molecular Pathways Molecular Pathways : Context-Dependent Approaches to Notch Targeting as Cancer Therapy

  2012cites this paper
• Notch1 Inhibition Alters the CD44hi/CD24lo Population and Reduces the Formation of Brain Metastases from Breast Cancer

  2011cites this paper
• Cells of origin in cancer

  2011cites this paper
• Notch signalling in solid tumours: a little bit of everything but not all the time

  2011cites this paper
• Cancer Stem Cells in Breast Cancer

  2011cites this paper
• Plasminogen activator uPA is a direct transcriptional target of the JAG1-Notch receptor signaling pathway in breast cancer.

  2011cites this paper